The use of controlled reperfusion strategies in cardiac surgery to minimize ischaemia/reperfusion damage

Cardiovascular Research

Volumn 83, Issue 2, 2009, Pages 262-268

  Beyersdorf, Friedhelm ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Cardiac surgery; Controlled reperfusion; Ischaemia reperfusion; Reperfusion

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; DILTIAZEM; FIBRINOLYTIC AGENT; MITOCHONDRIAL PERMEABILITY TRANSITION PORE;

ACUTE HEART INFARCTION; COMPARTMENT SYNDROME; CONTROLLED REPERFUSION; CORONARY ARTERY BYPASS GRAFT; DISEASE COURSE; DISEASE DURATION; EMBOLECTOMY; EMBOLISM; HEART MUSCLE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART MUSCLE REVASCULARIZATION; HEART SURGERY; HEART TRANSPLANTATION; HUMAN; HYPERCALCEMIA; HYPERGLYCEMIA; HYPERKALEMIA; ISCHEMIA; KIDNEY TRANSPLANTATION; LIMB; LIMB ISCHEMIA; LIVER TRANSPLANTATION; LUNG; LUNG TRANSPLANTATION; METABOLIC SYNDROME X; MORTALITY; MYOCARDIAL ISCHEMIA REPERFUSION INJURY; MYONEPHROPATHIC METABOLIC SYNDROME; ORGAN; PEDIATRIC SURGERY; PRIORITY JOURNAL; REPERFUSION INJURY; RESUSCITATION; REVIEW; RISK FACTOR; SALVAGE THERAPY; STROKE; SURGEON; SURGICAL APPROACH; SURGICAL TECHNIQUE;

CARDIAC SURGICAL PROCEDURES; CONSTRICTION; HUMANS; MYOCARDIAL REPERFUSION; MYOCARDIAL REPERFUSION INJURY; TREATMENT OUTCOME;

EID: 67650263683     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvp110     Document Type: Review

References (81)

1. Taber RE, Morales AR, Fine G. Myocardial necrosis and the postoperative low-cardiac-output syndrome. Ann Thorac Surg 1967;4:12-28.
2. Cooley D, Reul GJ, Wukasch DC. Ischemic contracture of the heart: 'Stone heart'. Am J Cardiol 1972;29:575-577.
3. Hultgren HN, Miyagawa M, Buch W, Angell WW. Ischemic myocardial injury during cardiopulmonary bypass surgery. Am Heart J 1973;85:167-176.
4. Jynge P, Hearse DJ, Braimbridge MV. Myocardial protection during ischemic cardiac arrest: a possible hazard with calcium-free cardioplegic infusates. J Thorac Cardiovasc Surg 1977;73:848-855.
5. Bretschneider HJ. Myocardial protection. Thorac Cardiovasc Surg 1980;28:295-302.
6. Follette DM, Mulder DG, Maloney JV Jr, Buckberg GD. Advantages of blood cardioplegia over continuous coronary perfusion or intermittent ischemia: experimental and clinical study. J Thorac Cardiovasc Surg 1978; 76:604-619.
7. Buckberg GD. Studies of controlled reperfusion after ischemia: when is cardiac muscle damaged irreversibly? J Thorac Cardiovasc Surg 1986;92:483-487.
8. Piper HM, Garcia-Dorado D, Ovize M. A fresh look at reperfusion injury. Cardiovasc Res 1998;38:291-300.
9. Yellon DM, Hausenloy DJ. Myocardial reperfusion injury. N Engl J Med 2007;357:1121-1135.
10. Kloner RA. Does reperfusion injury exist in humans? J Am Coll Cardiol 1993;21:537-545.
11. Yellon DM, Baxter GF. Reperfusion injury revisited: is there a role for growth factor signalling in limiting lethal reperfusion injury? Trends Cardiovasc Med 1999;9:245-49.
12. Vinten-Johansen J, Yellon DM, Opie LH. Postconditioning: a simple, clinically applicable procedure to improve revascularization in acute myocardial infarction. Circulation 2005;112:2085-2088.
13. Jennings RB, Ganote CE. Structural changes in myocardium during acute ischemia. Circ Res 1974;34(Suppl. 3):156-172.
14. Jennings RB, Sommers HM, Smyth GA, Flack HA, Linn H. Myocardial necrosis induced by temporary occlusion of a coronary artery in the dog. Arch Pathol 1960;70:68-78.
15. Kim JS, Lemasters JJ. Reactive oxygen species, but not Ca2+ overloading, trigger pH- and mitochondrial permeability transition-dependent death of adult rat myocytes after ischemia-reperfusion. Am J Physiol Heart Circ Physiol 2006;290:H2024-H2034.
16. Griffiths EJ, Halestrap AP. Mitochondrial non-specific pores remain closed during cardiac ischemia, but open upon reperfusion. Biochem J 1995; 307:93-98.
17. Hausenloy DJ, Yellon DM. The mitochondrial permeability transition pore: its fundamental role in mediating cell death during ischemia and reperfusion. J Mol Cell Cardiol 2003;35:339-341.
18. Allen BS, Rosenkranz ER, Buckberg GD, Vinten-Johansen J, Okamoto F, Leaf J. Studies of controlled reperfusion after ischemia. VII. High oxygen requirements of dyskinetic cardiac muscle. J Thorac Cardiovasc Surg 1986;92:543-552.
19. Allen BS, Okamoto F, Buckberg GD, Acar C, Partington M, Bugyi H et al. Studies of controlled reperfusion after ischemia. IX. Reperfusate composition: benefits of marked hypocalcemia and diltiazem on regional recovery. J Thorac Cardiovasc Surg 1986;92:564-572.
20. Allen BS, Okamoto F, Buckberg GD, Leaf J, Bugyi H. Studies of controlled reperfusion after ischemia. XII. Effects of 'duration' of reperfusate administration versus reperfusate 'dose' on regional functional, biochemical, and histochemical recovery. J Thorac Cardiovasc Surg 1986; 92:594-604.
21. Allen BS, Okamoto F, Buckberg GD, Bugyi H, Leaf J. Studies of controlled reperfusion after ischemia. XIII. Reperfusion conditions: critical importance of total ventricular decompression during regional reperfusion. J Thorac Cardiovasc Surg 1986;92:605-612.
22. Allen BS, Okamoto F, Buckberg GD, Bugyi H, Young H, LeafJ et al. Studies of controlled reperfusion after ischemia. XV. Immediate functional recovery after six hours of regional ischemia by careful control of conditions of reperfusion and composition of the reperfusate. J Thorac Cardiovasc Surg 1986;92:621-635.
23. Allen BS, Buckberg GD, Schwaiger M, Yeatman L, Tillisch J, Kawata N et al. Studies of controlled reperfusion after ischemia. XVI. Early recovery of regional wall motion in patients following surgical revascularization after eight hours of acute coronary occlusion. J Thorac Cardiovasc Surg 1986;92:605-612.
24. Beyersdorf F, Sarai K, Maul FD, Wendt T, Satter P. Immediate functional benefit after controlled reperfusion during surgical revascularization for acute coronary occlusion. J Thorac Cardiovasc Surg 1991;102:856-866.
25. Beyersdorf F, Acar C, Buckberg GD, Partington M, Sjöstrand F, Yang HH et al. Studies of prolonged acute regional ischemia. III. Early natural history of simulated single and multivessel disease with emphasis on remote myocardium. J Thorac Cardiovasc Surg 1989;98:368-380.
26. Beyersdorf F, Acar C, Buckberg GD, Partington MT, Okamoto F, Allen BS et al. Studies of prolonged acute regional ischemia. IV. Aggressive surgical treatment for intractable ventricular fibrillation after acute myocardial infarction. J Thorac Cardiovasc Surg 1989;98:557-566.
27. Beyersdorf F, Acar C, Buckberg GD, Partington MT, Okamoto F, Allen BS. Studies of prolonged acute regional ischemia. V. Metabolic support of remote myocardium during left ventricular power failure. J Thorac Car-diovasc Surg 1989;98:567-579.
28. Okamoto F, Allen BS, Buckberg GD, Young H, Bugyi H, Leaf J. Studies of controlled reperfusion after ischemia. XI. Reperfusate composition: interaction of marked hyperglycemia and marked hyperosmolarity in allowing immediate contractile recovery after four hours of regional ischemia. J Thorac Cardiovasc Surg 1986;92:583-593.
29. Ambrosio G, Weisfeldt ML, Jacobus WE, Flaherty JT. Evidence for a reversible oxygen radical-mediated component of reperfusion injury: reduction by recombinant human superoxide dismutase administered at the time of reflow. Circulation 1987;75:282-291.
30. Flaherty JT, Pitt B, Gruber JW, Heuser RR, Rothbaum DA, Burwll LR et al. Recombinant human superoxide dismutase (h-SOD) fails to improve recovery of ventricular function in patients undergoing coronary angioplasty for acute myocardial infarction. Circulation 1994;89:1982-1991.
31. Downey JM. Free radicals and their involvement during long-term myocardial ischemia and reperfusion. Annu Rev Physiol 1990;52:487-504.
32. Zweier JL, Talukder MA. The role of oxidants and free radicals in reperfusion injury. Cardiovasc Res 2006;70:181-190.
33. Kirklin JW, Barratt-Boyes BG. Cardiac Surgery. 2nd ed. New York: Churchill Livingstone; 1993. p129-166.
34. Vinten-Johansen J. Involvement of neutrophils in the pathogenesis of lethal myocardial injury. Cardiovasc Res 2004;61:481-497.
35. Engelman RM, Chandra R, Baumann G, Goldman RA. Myocardial reperfusion, a cause of ischemic injury during cardiopulmonary bypass. Surgery 1976;80:266-276.
36. Aosaki N, Haendchen R, Wyatt HL, Brien H, Erburu L, Meerbaum S et al. Accelerated return of cardiac function with gradual reperfusion after brief coronary occlusion. (Abstract). Clin Res 1981;29:175.
37. Okamoto F, Allen BS, Buckberg GD, Bugyi H, Leaf J. Studies of controlled reperfusion after ischemia. XIV. Reperfusate conditions: importance of ensuring gentle versus sudden reperfusion during relief of coronary occlusion. J Thorac Cardiovasc Surg 1986;92:583-593.
38. Allen BS, Buckberg GD, Fontan FM, Kirsh MM, Popoff G, Beyersdorf F et al. Superiority of surgical controlled reperfusion versus percutaneous transluminal coronary angioplasty in acute coronary occlusion. J Thorac Cardiovasc Surg 1993;105:864-884.
39. Loop FD, Higgins TL, Panda R, Pearce G, Estafanous FG. Myocardial protection during cardiac operations: decreased morbidity and lower cost with blood cardioplegia and coronary sinus perfusion. J Thorac Cardiovasc Surg 1992;104:608-618.
40. Beyersdorf F, Allen BS, Buckberg GD. Myocardial protection with integrated blood cardioplegia. In: Franco KL, Verrier ED (eds). Advanced Therapy in Cardiac Surgery. B.C. Decker, Inc.; 1999. p38-50.
41. Beyersdorf F, Mitrev Z, Sarai K, Eckel L, Klepzig H, Maul FD et al. Changing patterns of patients undergoing emergency surgical revascularization for acute coronary occlusion. J Thorac Cardiovasc Surg 1993;106:137-148.
42. Beyersdorf F, Mitrev Z, Ihnken K, Schmiedt W, Sarai K, Eckel L et al. Controlled limb reperfusion in patients having cardiac operations. J Thorac Cardiovasc Surg 1996;111:873-881.
43. Beyersdorf F. Protection of evolving myocardial infarction and failed PTCA. Ann Thorac Surg 1995;60:833-838.
44. Jennings RB, Schaper J, Hill ML, Steenberger CJ, Deiner KA. Effect of reperfusion late in the phase of reversible ischemic injury. Changes in cell volume, electrolytes, metabolites and ultrastructure. Circ Res 1985;56:262-278.
45. Becker LC, Schaper J, Jeremy E, Schaper W. Severity of ischemia determines the occurrence of myocardial reperfusion injury. (Abstract). Circulation 1991;84(Suppl. 2):254.
46. Beyersdorf F. Myocardial and endothelial protection for heart transplantation in the new millennium: lessons learned and future directions. J Heart Lung Transplant 2004;23:657-665.
47. Khonsari S, Sintek CF. Cardiac Surgery. Safeguards and Pitfalls in Operative Technique. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2008. p186-191.
48. Pearl JM, Drinkwater DC, Laks H, Stein DG, Capouya ER, Bhuta S. Leucocyte-depleted reperfusion of transplanted human hearts prevents ultrastructural evidence of reperfusion injury. J Surg Res 1992;52:298-308.
49. Pearl JM, Drinkwater DC, Laks H, Capouy ER, Gates RN. Leucocyte-depleted reperfusion of transplanted hearts: a randomized, double-blind clinical trial. J Heart Lung Transplant 1992;11:1082-1092.
50. Martin J, Sarai K, Yoshitake M, Haberstoh J, Takahashi N, Lutter G et al. Orthotopic transplantation of pig hearts harvested after 30 min of normothermic ischemia: controlled reperfusion with blood cardioplegia containing the Na+-H+-exchange inhibitor HOE 642. Eur J Cardiothorac Surg 1998;14:607-614.
51. Martin J, Lutter G, Ihling C, Siepe M, Wagner S, Sarai K et al. Myocardial viability 24 h after orthotopic heart transplantation from non-heart-beating donors. J Thorac Cardiovasc Surg 2003; 125:1217-1228.
52. Dhaliwal H, Kirshenbaum LA, Randhawa AK, Singal PK. Correlation between antioxidant changes during hypoxia and recovery on reoxygenation. Am J Physiol 1991;261:H632-H638.
53. Del Nido PJ, Mickle DAG, Wilson GJ, Benson LN, Coles JG, Trusler GA et al. Evidence of myocardial free radical injury during elective repair of tetralogy of Fallot. Circulation 1987;76:V174-V179.
54. Matheis G, Tixier DB, Buckberg GD, Ihnken K, Morita K, Sherman MP et al. Cardiopulmonary dysfunction produced by reoxygenation of immature hypoxemic animals supports by cardiopulmonary bypass: prevention by intravenous metabolic pre-treatment. J Thorac Cardiovasc Surg 1993; 105:513-519.
55. Ihnken K, Morita K, Buckberg GD, Winkelmann B, Young HH, Beyersdorf F. Controlling oxygen content during cardiopulmonary bypass to limit reper-fusion/reoxygenation injury. Transplant Proc 1995;27:2809- 2811.
56. Ihnken K, Morita K, Buckberg GD, Ignarro LJ, Beyersdorf F. Reduction of reoxygenation injury and nitric oxide production in the cyanotic immature heart by controlling pO2. Eur J Cardiothorac Surg 1995;9:410-418.
57. Blaisdell FW, Steele M, Allen RE. Management of acute lower extremity arterial ischemia due to embolism and thrombosis. Surgery 1978;84:822-834.
58. Domandy J, Heeck L, Vig C. Acute limb ischemia. Semin Vasc Surg 1999; 12:148-153.
59. Ouriel K. Acute limb ischemia. In: Rutherford RB ed. Vascular Surgery. Philadelphia, PA: Elsevier; 2005. p959-971.
60. Fecteau SR, Darling RC III, Roddy SP. Arterial Thromboembolism. In: Rutherford RB ed. Vascular Surgery. Philadelphia, PA: Elsevier; 2005. p971-986.
61. Hamovici H. Myopathic-nephrotic-metabolic syndrome associated with massive arterial occlusions. J Cardiovasc Surg 1973;14:589-600.
62. Hobson RW II, Lynch TG, Jamil Z, Karanfilian PG, Lee BC, Padberg FTJ et al. Results of revascularization and amputation in severe lower extremity ischemia: a five year clinical experience. J Vasc Surg 1985;2:174-185.
63. Beyersdorf F. Protection of the ischemic skeletal muscle. Thorac Cardiovasc Surg 1991;39:19-28.
64. Labbe R, Lindsey T, Walker P. The extent and distribution of skeletal muscle necrosis after graded periods of complete ischemia. J Vasc Surg 1987;6:152-157.
65. Walker PM. Ischemia/reperfusion injury in skeletal muscle. Ann Vasc Surg 1991;5:399-402.
66. Beyersdorf F, linger A, Wildhirt A, Kretzer U, Deutschländer N, Krüger S et al. Studies of reperfusion injury in skeletal muscle: preserved cellular viability after extended periods of warm ischemia. J Cardiovasc Surg 1991; 32:664-676.
67. Simon J, Beyersdorf F, Hallmann R, Seewald P, Zimmer G, Satter P. Free radical scavengers reduce the ischemic reperfusion injury in skeletal muscle. (Abstract). Thorac Cardiovasc Surg 1991;39(suppl.):93.
68. Defraigne JO, Pincemail J, Laroche C, Blaffort F, Limet R. Successful controlled limb reperfusion after severe prolonged ischemia. J Vasc Surg 1997;26:346-350.
69. Odeh M. The role of reperfusion-induced injury in the pathogenesis ofthe crush syndrome. N Engl J Med 1991;324:1417-1422.
70. Vogt PR, Lutz HJ, Akintürk HI, Roth P, Schânburg M, Menon AK et al. Prevention of postischemic tissue injury by controlled reperfusion: a preliminary study. Int J Angiol 2003;12:172-177.
71. Allen BS, Hartz RS, Buckberg GD, Schuler JJ. Prevention of ischemic damage using controlled limb reperfusion. J Card Surg 1998;13:224-227.
72. Anderson RJ, Cambria R, Kerr J, Hobson RW II. Sustained benefit of temporary limited reperfusion in skeletal muscle following ischemia. J Surg Res 1990;49:271-275.
73. Petrasek PF, Liauw S, Romaschin AD, Walker PM. Salvage of postischemic skeletal muscle by monoclonal antibodies blockade of neutrophil adhesion molecule CD18. J Surg Res 1994;56:5-12.
74. Rubin B, Tittley J, Chang G, Smith A, Lianw S, Romaschin A et al. A clinically applicable method for long-term salvage for postischemic skeletal muscle. J Vasc Surg 1991;13:58-68.
75. Beyersdorf F, Mitrev Z, Eckel L, Satter P. Controlled limb reperfusion as a new surgical technique to reduce postischemic syndrome. J Thorac Cardiovasc Surg 1993;106:378-380.
76. Schlensak C, Doenst T, Bitu-Moreno J, Beyersdorf F. Controlled limb reperfusion with a simplified perfusion system. Thorac Cardiovasc Surg 2000;48:274-278.
77. Wilhelm MP, Schlensak C, Hoh A, Knipping L, Mangold G, Dallmeier-Rojas D et al. Controlled reperfusion using a simplified perfusion system preserves function after acute and persistent limb ischemia: a preliminary study. J Vasc Surg 2005;42:690-694.
78. Vogt PR, von Segesser LK, Pagatto E, Lijovic T, Turina M. Simplified, controlled limb reperfusion and simultaneous revascularization for acute aortic occlusion. J Vasc Surg 1996;23:730-733.
79. Beyersdorf F, Schlensak C. Controlled reperfusion after acute and persistent limb ischemia. Semin Vasc Surg 2009;22:52-57.
80. Nolan JP, Laver SR, Welch CA, Harrison DA, Gupta V, Rowan K. Outcome following admission to lK intensive care units after cardiac arrest: a secondary analysis of the ICNARC Case Mix Programme Database. Anaesthesia 2007;62:1207-1216.
81. Trummer G, Förster K, Buckberg GD, Benk C, Heilmann C, Mader I et al. Neurologic recovery after 15min of normothermic cardiac arrest by pressure and flow-controlled circulation using a peripheral extracorporeal circuit. Circulation 2008;118:S170-S1471.